Michael H. Mulroy
CIK 1509725 · President and CEO · last filed 2025-07-02
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$1.01M
Companies
7
Total Filings
46
Lifetime Open-Market Net
-$2.35M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LCTX | Director | 298,555 | $1.27 | $379.2K | $32.4K | 9 | 2025-07-02 |
| Serina Therapeutics, Inc. (AGE) Delisted | Director | — | $11.10 | — | $0 | 1 | 2019-03-13 |
| Asterias Biotherapeutics, Inc. (AST) Delisted | President and CEO | 350,210 | — | — | $54.9K | 13 | 2019-03-05 |
| Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Director | 32,550 | — | — | $0 | 4 | 2018-07-03 |
| Asterias Biotherapeutics, Inc. (AST.WS) Delisted | President and CEO | 1,537 | — | — | $5.0K | 2 | 2017-09-27 |
| QUESTCOR PHARMACEUTICALS INC (QCOR) Delisted | See Remarks | 65,714 | — | — | -$2.44M | 11 | 2014-08-13 |
| BTX | Director | 70,000 | $9.03 | $632.1K | $0 | 3 | 2013-10-10 |
Recent Filings · Page 2 of 5
46 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2019-03-15 | — | Grant (A) | +194,271 | $0 | |
| 2019-03-13 | Serina Therapeutics, Inc. (AGE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-03-05 | Asterias Biotherapeutics, Inc. (AST) Delisted | Mixed | +176,018 | -$72.8K | EDGAR |
| 2018-08-29 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +3,141 | $5.0K | EDGAR |
| 2018-07-27 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +2,950 | $5.0K | EDGAR |
| 2018-07-03 | Lineage Cell Therapeutics, Inc. (BTX.WS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-06-27 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +3,067 | $5.0K | EDGAR |
| 2018-05-31 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +3,153 | $5.0K | EDGAR |
| 2018-04-27 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +3,752 | $5.0K | EDGAR |
| 2018-03-28 | Asterias Biotherapeutics, Inc. (AST) Delisted | Buy (P) | +2,839 | $5.0K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.